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Abstract 
Objective: To determine agreement on the adequacy of a sample by pipelle biopsy and conventional dilatation 
and curettage in patients with abnormal uterine bleeding.  
Study design: Cross-sectional study 
Setting and Duration of Study: Department of Obstetrics and Gyneacology, Islamic International Medical 
College Trust, Railway Hospital Rawalpindi. The study was carried out over a period of six months (11-07-2012 to 
 14-01-2013). 
Patients and Methods: 84 patients presented with abnormal uterine bleeding age 45 years and older, attended 
Gyneacology department of Railway Hospital Rawalpindi. Who qualified the inclusion criteria were enrolled in 
this study by non-probability consecutive sampling technique. The diagnostic intervention for endometrial 
sampling was by pipelle device and by conventional D&C (Dilatation & Curettage). Both procedures were 
performed in the OT at the same time. First, the pipelle sample was taken and was labeled as “A” then 
conventional D&C was performed and was labeled as “B”. Both samples were sent to the pathologist, who was 
blinded as to the method of sample collection for histopathology assessment.  Adequacy of the sample was 
assessed as per the operational definition. A database was made in SPSS version 17. Kappa statistics were applied 
to assess the agreement. 
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Results: Out of 84 patients, 80 (98.8%) of the patients had an adequate sample with Pipelle Biopsy as compared to 
conventional curettage and dilatation (D&C). We, therefore, recommend the use of pipelle biopsy as a first-line 
tool for endometrial assessment for our setups instead of D&C. 
Conclusion: Our study concluded that the Pipelle biopsy is a useful and convenient method for the patients and 
physicians as compared to D&C performed in the operating theatre. It is useful in obese and high-risk patients 
with minimum chances of perforation of the uterus due to its soft flexible tip. 
Keywords: Pipelle, Dysfunctional Uterine Bleeding, Dilatation and curettage, Abnormal uterine bleeding. 
 
 
Introduction 
 
Abnormal uterine bleeding (HMB and AUB) is the 
most common symptom in the women of reproductive 
age and it accounts for almost 33% of outpatient 
referrals.1,2 In addition to this, postmenopausal women 
presenting with bleeding also constitute a big 
proportion of patients presenting in outpatient clinics. 
Endometrial sampling for histopathology is often 
required for evaluation of heavy menstrual bleeding 
and post-menopausal bleeding to rule out 
premalignant lesions that are endometria hyperplasia 
and malignancy of endometrium.3,4,5,6,7  
Hysteroscopic guided endometrial sampling is the 
gold standard 8,9, but because of its invasiveness and 
inconvenience, traditionally in our setups, Dilatation, 
and Curettage (D&C) is performed without 
hysteroscopic guidance requiring hospitalization, 
complete laboratory workup, in operation theatre (OT) 
facilities, risks of general anesthesia, risk of infection 
and perforation of uterus. Recently, endometrial 
sampling is possible as an outpatient procedure due to 
the development of this equipment. These modern 
equipment enable this procedure to be carried out 
with much less risk as compared to conventional 
procedures that are diagnostic D & C. Pipelle is an 
instrument used for endometrial biopsy in OPD and it 
has revolutionized the management of abnormal 
uterine bleeding.8,10,11 Various devices are available 
including the pipelle curette (endocurrette, Midvale, 
Utah, USA).2 Pipelle endometrial biopsy is a useful 
office procedure for the assessment of patients with 
abnormal uterine bleeding. Now in a single visit, the 
patient can be evaluated to rule out pre-malignant/ 
malignant lesions of the endometrium as pipelle does 
not need in-patient admission and anesthesia. 
Moreover, the procedure-related risk of diagnostic 
D&C is remote. Regarding the accuracy of pipelle in 
ruling out malignancy, it is equally accurate than 
diagnostic D&C.12,13 
Thus endometrial sampling by pipelle in outpatient is 
a cost-effective procedure as it is convenient, safe, 
cheap, accurate and acceptable.14,15,16 Around 10% of 
the sampling done by pipelle is inadequate so that no 
tissue for the biopsy is available however in post-
menopausal women this percentage is increased to 
68%.17,18 
 
Patients and Methods 
 
This Cross-sectional study was conducted in the 
Department of Obstetrics and Gynecology, Islamic 
International Medical College Trust, Railway Hospital 
Rawalpindi from July 2012 to January 2013.  
84 patients, 45 years of age and older who presented 
with abnormal uterine bleeding were enrolled in this 
study after obtaining informed consent for 
participation and with approval from the hospital 
ethical committee.  
Patients with lower genital tract infections, polyp, the 
central endometrial thickness of less than 4 mm, 
bleeding disorders (deranged platelet count, 
PT/APTT, bleeding and clotting time), systemic 
disorders (thyroid and liver dysfunctions) and taking 
anticoagulants, were excluded from this study. Non-
probability consecutive sampling technique was used 
for the eligible woman after clinical assessment of the 
patient with complete history, examination, baseline 
investigations including pelvic ultrasound. 
The diagnostic intervention for endometrial sampling 
was done by pipelle device and by conventional D&C. 
Both procedures were performed in OT at the same 
time. First, the pipelle sample was taken and was 
labeled as “A” then conventional D&C was 
performed, and the sample was labeled as “B”. Both 
samples were sent to the pathologist for 
histopathology assessment. The pathologist was 
blinded to the method of sample collection. Adequacy 
of the sample was ensured according to the 
operational definition.   
A database was made in SPSS version 17. Quantitative 
variables like age and parity were presented as mean 
and standard deviation. Qualitative variables like 
agreement of histopathologists on the adequacy of the 
two procedures were presented as frequency and 
percentage.  Kappa statistics were applied to assess the 
agreement.  
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Result 
Descriptive statistics were calculated for the age of 
patients (years) in terms of mean standard deviation as 
45.95+3.03, in which the minimum number of patients 
were of 40 years and the maximum number of patients 
was 57 years. 37 (44%) patients fall in 35 – 45 years and 
47 (56%) of patients fall in 46 – 55 years.   
 
Table:1 Comparison of age with parity 
Age Parity Frequency Percent Vali
d % 
Cumulative 
% 
40-
45 
1-3 6 17.1 17.1 17.1 
4-6 27 77.1 77.1 94.3 
>7 2 5.7 5.7 100.0 
Total 35 100.0 100.0   
46-
50 
1-3 8 17.8 17.8 17.8 
4-6 36 80.0 80.0 97.8 
>7 1 2.2 2.2 100.0 
Total 45 100.0 100.0   
>50 4-6 4 100.0 100.0 100.0 
 
 
 
 
 
 
 
 
 
 
 
 
Figure-I: Age distribution of study participants 
 
Figure-II: Parity distribution according to the Age 
group 
 
Mean standard deviations of parity of 84 patients were 
4.71+1.51, whereas the frequency and percentages of 
multipara were 50(60%) and grand multi 33(39%), and 
only 1(1%) was of nulliparity.  
 
Table2: Comparison of Diagnosis with age and 
parity 
Diagnosis Age Years To
tal 
Parity(n) To
tal 
40-
45 
46-
50 
>5
0 
1--
3 
4--
6 
>
7 
Continuou
s Vaginal 
Bleeding 
2 1  3  3  3 
Heavy 
Menstrual 
Bleeding 
2 1  3  2 1 3 
Intermens
trual 
Bleeding 
 2  2  2  2 
Irregular 
Menstruat
ion 
 1  1  1  1 
Menorrha
gia 
19 25 3 47 10 39 1 50 
Menorrha
gia 
secondary 
to vaginal 
discharge 
1 1  2      
Menorrha
gia with 
Rt. 
Adnexal 
mass 
1   1      
Oligomen
orrhagia 
2 2  4 1 3  4 
Polymenn
orrhagia 
6 9 1 16 2 13 1 16 
Post-
Menopaus
al 
Bleeding 
2 3   5 1 4   5 
Total 35 45 4 84 14 67 3 84 
Patients came with different kinds of diagnoses with 
abnormal uterine bleeding, in which the maximum 
number of patients came with menorrhagia i.e. with 
47(56%), whereas 16(19%) came with inter-menstrual 
bleeding and only one patient come with irregular 
menstruation.  
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Table. No. 3: Agreement on the adequacy of a sample 
by Pipelle Biopsy and  D&C 
    Agreement on the 
adequacy of a 
sample by D&C  
Total 
    Yes No 
Agreement on 
the adequacy 
of a sample by 
Pipelle Biopsy 
Yes 80 0 80 
98.80% 0.00% 95.20% 
No 1 3 4 
1.20% 100.00% 4.80% 
Total 81 3 84 
100.00% 100.00% 100.00% 
 
Adequacy of sample performed according to inclusion 
criteria of the study, in which kappa statistics were 
applied between the pipelle biopsy and conventional 
dilatation and curettage (D & C) in patients with 
abnormal uterine bleeding. Among 84 patients, 80 
(98.8%) of the patients, came with agreement on the 
adequacy of the sample, between both the procedures 
as shown in Table No.3.  
 
Table:4  k-Value showing the Measurement of 
agreement of adequacy for Pipelle Biopsy and D&C 
  Value Approx. 
Sig. 
  Measure of Agreement of Kapa 0.851 0 
  Total Number of Patients (n) 84   
 
The kappa statistics (k = 0.851) were calculated which 
was statistically significant (p-value = 0.000), which 
means that there is almost a perfect agreement on the 
adequacy of pipelle biopsy compared to conventional 
curettage and dilatation (D & C) as shown in the Table 
No. 4. 
 
Discussion 
 
Irregular vaginal bleeding accounts for 70% of 
referrals to gynecologists in the pre-menopausal age 
group. There is a need for endometrial assessment in 
these patients and different methods for evaluation are 
being developed which ranges from traditional 
diagnostic D&C, hysteroscopic guided biopsies and 
outpatient endometrial sampling by different 
instruments like pipelle biopsy forceps. These 
procedures are further compared to their adequacy, 
accuracy, reliability, and acceptability. Diagnostic 
D&C is replaced by outpatient pipelle biopsy in the 
developed world but it is still practiced in our 
hospitals for endometrial assessment.  
The current study shows, the age of patients (years) in 
terms of mean standard deviation as  
45.95+3.03, in which the minimum age of the patient 
was 40 years and the maximum was 57 years and 
patients in the age group of 51 and above are only 3%. 
The mean standard deviation of parity of 84 patients 
were 4.71+1.51, whereas the frequency and 
percentages of multipara were 50(59.5%) and grand 
multi 33(39.3%), and only one patient was of 
nulliparous. In contrast, with our study, the study of 
Bano et.al. Revealed that grand multiparas were 58% 
(36) and para 3 and less were 42% (26) 19 & none of the 
patients was nulliparous. On the contrary, the results 
of the study of Yasmin et.al. showed the percentages of 
Nulliparous, multiparous and grand multiparous as 
2%, 45%, and 53% respectively.19  
In the current study, patients came with various kinds 
of diagnoses with abnormal uterine bleeding, in which 
the maximum number of patients came with 
menorrhagia i.e. with 47(56%), whereas 16(19%) came 
with intermenstrual bleeding and only one patient 
came with irregular menstruation. Similarly, in the 
study by Yasmin et.al. the percentages of menorrhagia 
are 38%, irregular menstrual bleeding is 48%, 
postmenopausal bleeding is 14% which are almost 
similar to the current study.19 
In our study, adequacy of sample performed 
according to inclusion criteria of the study, in which 
kappa statistics was applied between the pipelle 
biopsy and conventional dilatation and curettage (D & 
C) in patients with abnormal uterine bleeding. Out of 
84 patients, 80 (98.8%) of the patients were with 
agreement on the adequacy of the sample between 
both the procedures. The kappa statistics (k = 0.851) 
were calculated which was statistically significant (p-
value = 0.000), which means that there is almost a 
perfect agreement on the adequacy of pipelle biopsy 
compared to conventional dilatation and curettage (D 
& C). Likewise, in the study of Williams A, Brechin S, 
Porter A, Warner P, Critchley H shows that in 200 
high-risk women, adequate samples were significantly 
more likely to be obtained by Tao Brush than Pipelle 
(P < 0.001).17 The adequacy of a specimen by pipelle 
biopsy was 92%. Similarly, the study of Bano I, Anwar 
A, Tahir N, Shaheen T  shows pipelle biopsy forceps is 
reliable as compared to D&C.20 On the contrary, in the 
study of Yasmin F, Farrukh R, Kamad F, it is 
determined that Pipelle biopsy has reduced the 
number of D&Cs performed in operation theatres due 
to its cost-effectiveness, adequacy, and acceptability.  
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Now the patients are assessed during their first visit 
by pipelle biopsy and for confirmation of 
premalignant or malignant nature of the disease at an 
earlier stage for better management of the patient [19]. 
Likewise, in a study conducted by Behmanfar F. 
Khanchchian T. Mazoochi MS, Fahiminead T at 
Kashan compared the efficiency of pipelle on 200 
patients and concluded that pipelle is 94% efficient as 
compared to D&C which is 93%.21 
So, our study results were evident that pipelle 
endometrial biopsy is better as compared to D&C and 
pipelle is an instrument of choice for endometrial 
assessment in peri menopausal and post-menopausal 
women and we advise pipelle biopsy forceps as a tool 
for endometrial assessment instead of D&C. 
 
Conclusion 
 
The conclusion of the study was that the Pipelle biopsy 
is a useful method. It is convenient for the patient and 
doctor as well and noninvasive as compared to D&C 
and can be performed in OPD. It can replace the D&C 
having added risks of anesthesia, infections, and 
requirement of operation theatre facilities. Pipelle has 
a soft flexible tip so there are very fewer chances of 
perforation and it can be done on the first visit so that 
the time for diagnosing the nature of the disease is 
minimized. 
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